NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 213 filers reported holding NEOGENOMICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,280,000 | +173.5% | 66,936 | +213.7% | 0.06% | +146.2% |
| Q2 2019 | $468,000 | +76.6% | 21,336 | +1.4% | 0.03% | +52.9% |
| Q4 2018 | $265,000 | -51.2% | 21,036 | -40.6% | 0.02% | -32.0% |
| Q3 2018 | $543,000 | +422.1% | 35,422 | +166.3% | 0.02% | +400.0% |
| Q1 2017 | $104,000 | -73.7% | 13,300 | -73.0% | 0.01% | -75.0% |
| Q2 2016 | $395,000 | +94.6% | 49,185 | +62.9% | 0.02% | +122.2% |
| Q1 2016 | $203,000 | -27.5% | 30,185 | -43.9% | 0.01% | -30.8% |
| Q3 2014 | $280,000 | +536.4% | 53,807 | +259.2% | 0.01% | +550.0% |
| Q3 2013 | $44,000 | – | 14,981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |